Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:1415:103-107.
doi: 10.1007/978-3-031-27681-1_16.

Analysis of CRB1 Pathogenic Variants Correctable with CRISPR Base and Prime Editing

Bruna Lopes da Costa  1   2   3 , Laura A Jenny  2   3 , Irene H Maumenee  2   3 , Stephen H Tsang  1   2   3   4   5   6 , Peter M J Quinn  7   8
Affiliations

Analysis of CRB1 Pathogenic Variants Correctable with CRISPR Base and Prime Editing

Bruna Lopes da Costa et al. Adv Exp Med Biol. 2023.

Abstract

The mouse and human retina contain three major Crumbs homologue-1 (CRB1) isoforms. CRB1-A and CRB1-B have cell-type-specific expression patterns making the choice of gene augmentation strategy unclear. Gene editing may be a viable alternative for the amelioration of CRB1-associated retinal degenerations. To assess the prevalence and spectrum of CRB1-associated pathogenic variants amenable to base and prime editing, we carried out an analysis of the Leiden Open Variation Database. Editable variants accounted for 54.5% for base editing and 99.8% for prime editing of all CRB1 pathogenic variants in the Leiden Open Variation Database. The 10 most common editable pathogenic variants for CRB1 accounted for 34.95% of all pathogenic variants, with the c.2843G>A, p.(Cys948Tyr) being the most common editable CRB1 variant. These findings outline the next step toward developing base and prime editing therapeutics as an alternative to gene augmentation for the amelioration of CRB1-associated retinal degenerations.

Keywords: Base editing; Crumbs-homologue-1 (CRB1); Leber congenital amaurosis (LCA); Prime editing; Retinitis pigmentosa (RP).

PubMed Disclaimer

References

    1. Boon N, Alves CH, Mulder AA, Andriessen CA, Buck TM, Quinn PMJ, Vos RM, Koster AJ, Jost CR, Wijnholds J. Defining phenotype, tropism, and retinal gene therapy using Adeno-Associated Viral Vectors (AAVs) in new-born brown Norway rats with a spontaneous mutation in Crb1. Int J Mol Sci. 2021;22:1–27. - DOI
    1. Buck TM, Vos RM, Alves CH, Wijnholds J. AAV-CRB2 protects against vision loss in an inducible CRB1 retinitis pigmentosa mouse model. Mol Ther – Methods Clin Dev, vol. 20; 2020. p. 423.
    1. Bujakowska K, Audo I, Mohand-Säid S, Lancelot ME, Antonio A, Germain A, Eveillard TĹ, Ḿelanie L, Saraiva JP, Lonjou C, Carpentier W, Sahel JA, Bhattacharya SS, Zeitz C. CRB1 mutations in inherited retinal dystrophies. Hum Mutat. 2012;33:306–15. - DOI - PubMed
    1. Chen PJ, Hussmann JA, Yan J, Knipping F, Ravisankar P, Chen P-F, Chen C, Nelson JW, Newby GA, Sahin M, Osborn MJ, Weissman JS, Adamson B, Liu DR. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 2021;184:1–18. - DOI
    1. Costa BLD, Levi SR, Eulau E, Tsai YT, Quinn PMJ. Prime editing for inherited retinal diseases. Front Genome Ed. 2021;3:775330. - DOI - PubMed - PMC

LinkOut - more resources